NASDAQ:ALZN | Free Cash Flow | Alzamend Neuro, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-04-30 to 2026-04-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-04-30-$2.8M
2025-07-31-$2.36M
2025-04-30-$688,705.00
2024-07-31-$1.06M
2024-04-30-$1.43M
2023-07-31-$3.3M
2023-04-30-$2.24M
2022-07-31-$2.54M
2022-04-30-$1.56M
2021-07-31-$1.22M
2021-04-30-$1.26M
2020-07-31-$205,096.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-04-30-$8.07M
2025-04-30-$6.57M
2024-04-30-$8.27M
2023-04-30-$8.92M
2022-04-30-$6.61M
2021-04-30-$2.71M
2020-04-30-$2.35M